Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
Wangpaichitr M, Wu C, Li YY, Nguyen DJM, Kandemir H, Shah S, Chen S, Feun LG, Prince JS, Kuo MT, Savaraj N.
Wangpaichitr M, et al. Among authors: nguyen djm.
Oncotarget. 2017 Jul 25;8(30):49275-49292. doi: 10.18632/oncotarget.17568.
Oncotarget. 2017.
PMID: 28525376
Free PMC article.